Michael Heltzen Acquires 1,984 Shares of Invizyne Technologies Inc. (NASDAQ:IZTC) Stock

Invizyne Technologies Inc. (NASDAQ:IZTC) CEO Michael Heltzen bought 1,984 shares of the stock in a transaction dated Friday, November 15th. The stock was purchased at an average cost of $11.10 per share, with a total value of $22,022.40. Following the completion of the purchase, the chief executive officer now directly owns 1,984 shares in the company, valued at approximately $22,022.40. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

Invizyne Technologies Trading Up 0.8 %

Shares of NASDAQ:IZTC opened at $13.11 on Thursday. Invizyne Technologies Inc. has a 1-year low of $8.50 and a 1-year high of $14.19.

About Invizyne Technologies

Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.